StockNews.AISignal intelligence
Company intelligence

HSY

The Hershey Company · NYSE · Consumer Defensive

Price$174.34+1.25% · +$2.15
Market cap35.36BEquity value
P / E24.0Trailing ratio
Volume1.33MLatest session
Market data

HSY price chart

TradingView
Related signals
1 min delayed

Browse public HSY signals with their source context and measured market impact. Open any signal for its permanent analysis page.

HSYAug 19, 2026+3.05% since signal

Hershey Poised to Benefit If Halloween Healthier-Snack Trend Materializes

Halloween candy demand may shift toward healthier options, highlighting product reformulation as a key driver. Hershey is highlighted as the United States’ largest chocolate-maker pursuing healthier offerings, signaling potential near-term upside from category adaptation. The catalyst is consumer preference changes during peak Halloween season; the impact will depend on HSY’s execution and consumer uptake of new formats.

View signal analysis
HSYJul 30, 2026-4.89% since signal

Hershey Q2 Sales Beat Fueled by Pricing Power and Reese’s Demand

Hershey reported a stronger-than-expected second-quarter with sales driven by higher prices and steady demand for Reese's and Dot's Pretzels. The combination supported volumes and likely margins in a cautious spending environment. The earnings beat underscores pricing power as a near-term catalyst, though the stock may hinge on forthcoming guidance and cost outlook.

View signal analysis
HSYJul 22, 2026+0.60% since signal

Hershey Positions Halloween as Micro-Season With AI-Driven Strategy

HSY is shifting Halloween into micro-seasons, leveraging AI-driven marketing and tighter cross-functional teams to react faster. The company is expanding into pre-season cues, non-chocolate formats, and a collaboration with Amazon to deliver ready-made bowls, aiming to counter last year's weak Halloween performance and rising cocoa costs. If successful, the strategy could lift seasonal margins and brand engagement into 2026.

View signal analysis
HSYApr 30, 2026-0.59% since signal

Growing GLP-1 Drug Adoption Boosts Hershey's Mint Sales

Hershey is witnessing robust growth in its mint and gum sales, driven by increased demand from GLP-1 drug users experiencing side effects such as dry mouth. This trend has contributed significantly to Hershey's overall quarterly revenue growth exceeding 10%. However, despite positive sales results, shares dropped more than 2% after the earnings report.

View signal analysis
Research

Company intelligence